Patient Support Services Contact Us
Image: Coherus Investors

Income Statement

  Year Ending Dec 2019 (Update) Year Ending Dec 2018 (Update) Year Ending Dec 2017 (Update) Year Ending Dec 2016 (Update) Year Ending Dec 2015 (Update)
Net Sales 356.07 0.00 1.56 190.11 30.04
Revenue 356.07 0.00 1.56 190.11 30.04
Total Revenue 356.07 0.00 1.56 190.11 30.04
Cost of Revenue 17.08 -- -- -- --
Cost of Revenue, Total 17.08 -- -- -- --
Gross Profit 338.99 -- -- -- --
Selling/General/Administrative Expense 116.47 74.72 53.01 39.21 27.76
Labor & Related Expense 20.57 19.46 18.29 12.39 8.29
Selling/General/Administrative Expenses, Total 137.04 94.18 71.30 51.60 36.05
Research & Development 94.19 110.24 162.39 254.44 213.06
Total Operating Expense 248.30 204.42 233.69 306.04 249.11
Operating Income 107.77 -204.42 -232.14 -115.93 -219.07
Interest Expense - Non-Operating -17.60 -9.68 -9.55 -7.98 -0.03
Interest Expense, Net Non-Operating -17.60 -9.68 -9.55 -7.98 -0.03
Interest Income (Expense), Net-Non-Operating, Total -17.60 -9.68 -9.55 -7.98 -0.03
Other Non-Operating Income (Expense) 2.61 4.69 3.40 -3.88 -4.84
Other, Net 2.61 4.69 3.40 -3.88 -4.84
Net Income Before Taxes 92.78 -209.41 -238.29 -127.79 -223.94
Income Tax – Total 2.94 -- 0.00 -- --
Income After Tax 89.83 -209.41 -238.29 -127.79 -223.94
Minority Interest 0.00 0.07 0.12 0.45 0.68
Net Income Before Extraordinary Items 89.83 -209.34 -238.17 -127.34 -223.26
Extraordinary Item -- -- 0.00 -- --
Total Extraordinary Items -- -- 0.00 -- --
Net Income 89.83 -209.34 -238.17 -127.34 -223.26
Income Available to Common Excluding Extraordinary Items 89.83 -209.34 -238.17 -127.34 -223.26
Income Available to Common Stocks Including Extraordinary Items 89.83 -209.34 -238.17 -127.34 -223.26
Basic Weighted Average Shares 69.68 65.03 53.13 41.91 37.12
Basic EPS Excluding Extraordinary Items 1.29 -3.22 -4.48 -3.04 -6.01
Basic EPS Including Extraordinary Items 1.29 -3.22 -4.48 -3.04 -6.01
Dilution Adjustment -- -- -- -- --
Diluted Net Income 89.83 -209.34 -238.17 -127.34 -223.26
Diluted Weighted Average Shares 73.19 65.03 53.13 41.91 37.12
Diluted EPS Excluding Extraordinary Items 1.23 -3.22 -4.48 -3.04 -6.01
Diluted EPS Including Extraordinary Items 1.23 -3.22 -4.48 -3.04 -6.01
DPS - Common Stock Primary Issue -- -- -- -- 0.00
Gross Dividends - Common Stock 0.00 0.00 0.00 0.00 0.00
Impairment-Assets Held for Use, Supplemental 0.10 3.90 0.60 -- --
Non-Recurring Items, Total 0.10 3.90 0.60 -- --
Total Special Items 0.10 3.90 0.60 -- --
Normalized Income Before Taxes 92.88 -205.51 -237.69 -127.79 -223.94
Effect of Special Items on Income Taxes 0.00 0.00 0.00 -- --
Income Taxes Excluding Impact of Special Items 2.95 0.00 0.00 -- --
Normalized Income After Taxes 89.93 -205.51 -237.69 -127.79 -223.94
Normalized Income Available to Common 89.93 -205.44 -237.57 -127.34 -223.26
Basic Normalized EPS 1.29 -3.16 -4.47 -3.04 -6.01
Diluted Normalized EPS 1.23 -3.16 -4.47 -3.04 -6.01
Depreciation, Supplemental 3.30 3.24 3.40 3.00 1.90
Interest Expense, Supplemental 17.60 9.68 9.55 7.98 0.03
Rental Expense, Supplemental 2.40 2.20 2.30 1.70 1.80
Stock-Based Compensation, Supplemental 33.59 34.80 33.40 23.24 14.75
Minority Interest, Supplemental 0.00 0.07 0.12 0.45 0.68
Research & Development Expense, Supplemental 94.19 110.24 162.39 254.44 213.06
Audit-Related Fees, Supplemental -- 1.87 1.55 1.81 2.05
Audit-Related Fees -- 0.00 0.00 0.00 0.00
Tax Fees, Supplemental -- 0.00 0.00 0.00 0.00
All Other Fees Paid to Auditor, Supplemental -- 0.00 0.00 0.00 0.03
Gross Margin 95.20 -- -- -- --
Operating Margin 30.27 -- -14,918.77 -60.98 -729.23
Pretax Margin 26.06 -- -15,314.01 -67.22 -745.44
Effective Tax Rate 3.17 -- -- -- --
Net Profit Margin 25.23 -- -15,306.56 -66.98 -743.18
Normalized EBIT 107.87 -200.52 -231.54 -115.93 -219.07
Normalized EBITDA 111.17 -197.28 -228.14 -112.93 -217.17
For a more complete picture of our financial results, please review our SEC Filings

Copyright Thomson Reuters Corporation